Local evolutionary patterns of human respiratory syncytial virus derived from whole-genome sequencing by Agoti, Charles N. et al.
Local Evolutionary Patterns of Human Respiratory Syncytial Virus
Derived from Whole-Genome Sequencing
Charles N. Agoti,a James R. Otieno,a Patrick K. Munywoki,a Alexander G. Mwihuri,a Patricia A. Cane,b D. James Nokes,a,c
Paul Kellam,d,e Matthew Cottend
KEMRI-Wellcome Trust Research Programme, Kilifi, Kenyaa; Public Health England, Salisbury, United Kingdomb; University of Warwick, School of Life Sciences and WIDER,
Warwick, United Kingdomc; The Wellcome Trust Sanger Institute, Cambridge, United Kingdomd; Division of Infection Immunity, University College London, London,
United Kingdome
ABSTRACT
Human respiratory syncytial virus (RSV) is associated with severe childhood respiratory infections. A clear description of local
RSVmolecular epidemiology, evolution, and transmission requires detailed sequence data and can inform new strategies for
virus control and vaccine development. We have generated 27 complete or nearly complete genomes of RSV from hospitalized
children attending a rural coastal district hospital in Kilifi, Kenya, over a 10-year period using a novel full-genome deep-se-
quencing process. Phylogenetic analysis of the new genomes demonstrated the existence and cocirculation of multiple genotypes
in both RSV A and B groups in Kilifi. Comparison of local versus global strains demonstrated that most RSV A variants observed
locally in Kilifi were also seen in other parts of the world, while the Kilifi RSV B genomes encoded a high degree of variation that
was not observed in other parts of the world. The nucleotide substitution rates for the individual open reading frames (ORFs)
were highest in the regions encoding the attachment (G) glycoprotein and the NS2 protein. The analysis of RSV full genomes,
compared to subgenomic regions, providedmore precise estimates of the RSV sequence changes and revealed important pat-
terns of RSV genomic variation and global movement. The novel sequencing method and the new RSV genomic sequences re-
ported here expand our knowledge base for large-scale RSV epidemiological and transmission studies.
IMPORTANCE
The new RSV genomic sequences and the novel sequencing method reported here provide important data for understanding
RSV transmission and vaccine development. Given the complex interplay between RSV A and RSV B infections, the existence of
local RSV B evolution is an important factor in vaccine deployment.
Human respiratory syncytial virus (RSV) is a leading viral causeof severe respiratory infection during infancy and early child-
hood and among immunocompromised populations (1, 2). Glob-
ally, the virus is estimated to be responsible for 30million episodes
of acute lower respiratory tract infections (RTIs) and more than
50,000 deaths annually in children under 5 years of age (3). RSV
infections throughout the world consistently occur as annual or
biennial epidemics, and persons of all ages can be infected with
diverse clinical outcomes ranging frommild upper RTIs to severe
pneumonia or bronchiolitis (2, 4). A vaccine against RSV is not yet
available (5). Careful analyses of RSV molecular epidemiology,
evolution, and transmission are essential for defining the circulat-
ing viruses, for characterizing antigenic variation, and for tracking
transmission patterns. The outcome of these studies can support
new strategies for RSV control and vaccine use and development.
It has long been known that children suffer repeated RSV in-
fections throughout life (6, 7). The ability of the virus to continue
to infect previously exposed individuals is thought to be linked to
an ability to bypass preexisting immune responses (8). Sequence
variation in attachment (G) protein in consecutive years (9) is
thought to be part of this mechanism; also, the global existence of
two groups, A and B, and their alternating infection incidences
may play a role (10, 11). The transmissibility of RSV group A
(RSVA) is estimated to be slightly higher than that of RSV group B
(RSVB) (12), and RSVA infections are more frequent than RSVB
infections (12). An additional important feature of RSV infection
is the apparently rapid global dispersion of newRSV variants (13).
Indeed, genetically similar viruses cluster more by time than by
location, suggesting rapid global movement of new variants (14).
RSV molecular pathology and epidemiology have been reviewed
in detail elsewhere (2, 4, 15, 16).
Historically, RSV molecular epidemiology has focused on the
900-bp region encoding the G protein (15, 17). The G protein
together with the fusion (F) protein are important targets of hu-
man protective antibody responses (8, 15), with changes in this
region thought to be driven by pressure to avoid host immune
responses. Although studies of the sequence variability of RSV
have concentrated on G gene variability, given the rapid infection
pace but relatively low evolutionary rate of RSV, transmission
studies over short periods require the stronger evolutionary signal
provided by the full virus genome sequence (15,200 nucleotides
[nt]: 11 open reading frames [ORFs] and noncoding regions).
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There is also a need to understand the nature of variation of im-
mune targets other than theGprotein. Advances in primer design,
sequencing technology, and sequence assembly algorithms now
allow full-genome sequencing for a number of viruses, including
RSV (18–23), norovirus (24), and Middle East respiratory syn-
drome (MERS) coronavirus (25, 26).
The current work describes RSV genome evolution across a set
of clinical samples collected from children who presented with
severe RSV disease in a rural coastal Kenyan hospital using a novel
RSV whole-genome sequencing (WGS) approach optimized for
small amounts of clinical diagnostic samples. The sequence data
provide an update of the genome-wide diversity of circulating
RSV strains in this part of Kenya, including both RSVA and RSVB
and the recently reemerged groupB genotypeGB3 (27). The novel
genomes support previous conclusions on patterns of local RSV
variation relative to global RSV diversity and reveal a significant
difference in local evolution of RSVA versus RSVB.
MATERIALS AND METHODS
Primer design.All RSV sequences available (August 2012) with lengths of
14,000 nt were collected and sorted by group, yielding 138 RSVA and 38
RSVB genomes. The sequences for each groupwere pooled and sliced into
33-nt strings with a 1-nt step size. The 33-mers were filtered to remove
sequences with ambiguous nucleotides, and the frequency of each se-
quence within the set was determined. The 33-nt sequences were then
trimmed to a calculated melting temperature (Tm) of 58°C, discarding
sequences mapping to human rRNA, with GC contents of 30% or
65%, or with a single nucleotide frequency of60%. The RSV genome
was divided into six 3-kb segments overlapping by 300 nt. All sequences
were mapped to an RSVA or RSVB reference strain, and the two most
frequent primersmapping within 300 nt of the end of each ampliconwere
selected. The reverse complement of the downstream sequences was pre-
pared. To ensure amplification of the far ends of the genomes, two addi-
tional primers were included from the 5=- and 3=-terminal genomic re-
gions. A summary of the primer sequences and their predicted target
sequences across all known RSV genomes is presented in Table 1.
Clinical samples.Viral nucleic acid for sequencingwas extracted from
RSV-positive clinical specimens (nasopharyngeal swabs [NPS] or washes)
collected from children under 5 years old admitted to the Kilifi District
Hospital (KDH) with severe or very severe pneumonia between 2002 and
2012. RSV infection was diagnosed with an indirect immunofluorescence
antibody technique (IFAT; Light Diagnostics). Details of the study that
provided the samples sequenced in this study have been previously pro-
vided (28). Informed consent was obtained from a parent or guardian on
behalf of each child before specimen collection, and the KEMRI Ethics
Review Committee approved all protocols. Additional details on the sam-
ples are provided in Table 2.
RNA extraction, RT, and PCR. Viral RNA was extracted with the
QIAmp extraction kit (Qiagen, United Kingdom) from a starting NPS
specimen volume of 140 l and final elution volume of 60 l. Reverse
transcription (RT) of RNA molecules was performed with the forward
primers for each of the six amplicons. A separate RT reaction was per-
formed for each amplicon. Typically, the 20-l reaction mixture con-
tained 2l of sample RNA. A 5-l aliquot of the resulting cDNAwas used
in each 25-l PCR mixture. The PCR mixture was incubated at 98°C for
30 s, followed by 40 cycles of 98°C for 10 s, 53°C for 30 s, and 72°C for 3.0
min and a final extension of 72°C for 10.0min. Following PCR, aliquots of
the products were run on a 0.6% agarose gel to monitor amplification
success, and the products from the 6 reactions for each sample were
pooled for Illumina library preparation.
Deep sequencing. Sequencing of the pooled amplicons was per-
formed with Illumina MiSeq. Samples were multiplexed at 15 to 20 per
MiSeq run and processed as paired-end reads (2  149 nt), generating
approximately 1.5million reads per sample. Raw sequence data were pro-
cessedwithQUASR (29) to remove low-quality (median Phred 35) and
adapter-containing reads, and de novo assembly with SPAdes (30) was
performed. RSV contigs were identified by BLASTN analysis, and low-
coverage contigs were excluded.Where necessary, partial but overlapping
genome contigs were combined using Sequencher (v5.2.4). All final viral
genomeswere examined for appropriate assembly based on length and the
presence of the expected intact RSV open reading frames.
Protein changes.After sorting by virus group (RSV group A or B), the
genomic region under investigation was translated, the protein sequence
was aligned using MAFFT (31), and protein differences from the consen-
sus sequence of the group were visualized and quantitated using Python
scripts.
Reference data set. A comprehensive RSV genome data set was gen-
erated from the GenBank database using as a starting set all reported RSV
genomes. The search was conducted on 28 September 2014 using the
search term “txid11250 [Organism]) AND 13500[SLEN]: 17000[SLEN].”
Genomes with multiple ambiguous bases, lacking country of detection or
date of collection (year), or from patent depositions were excluded. The
newly sequenced Kilifi RSV genomes for each group were combined with
those from GenBank in the subsequent analysis. Thinned representative
reference sets were prepared by using the usearch algorithm (32).
Phylogenetic analyses. Phylogenetic trees of the genome sequences
and selected genomic regions were constructed using the Bayesian meth-
ods in MrBayes program v3.2.1 (http://mrbayes.sourceforge.net/index
.php) under the general time reversible model of evolution. RSVA and
RSVB were analyzed separately using both the total data set and the
thinned data sets. The viruses within the groups were assigned to geno-
types based on the clustering pattern of theGORF portion sequences with
reference sequences representative of the previously described RSV geno-
types: for RSVA, strains representing GA1-7, SAA1, and ON1, and for
RSVB, strains representing GA1-4, SAB1-SAB4, and BA (11, 33–35). Phy-
logenetic trees were visualized in FigTree v1.4.2.
Evolutionary analyses. Nucleotide substitution rates and estimates
for time to most recent common ancestor (tMRCA) were obtained from
the usearch-thinned data sets, using uclust to remove genomes closer than
ID 0.99 (32). The rates and tMRCA estimates were calculated in BEAST
v1.7.5 (36) both for full genomes and for the individual ORFs.
Nucleotide sequence accession numbers. The final set of RSV se-
quences was deposited inGenBankwith the following accession numbers:
KP317916 to KP317956.
RESULTS
Two sets of reverse transcription and PCR primers were selected
from all available RSVA and RSVB genomic sequence data based
on frequency, location, and predicted PCR function (see Table 1
for further details). The general pattern of primer sites and the
locations of primer targets inRSVAandRSVB genomes are shown
in Fig. 1A. Actual PCR results are shown in Fig. 1B for RSVA and
RSVB samples, with PCR products of the expected size obtained
for all 6 amplicons. These primers were used as part of a deep-
sequencing process for RSV combining the full cDNApreparation
and genome amplification, deep sequencing with IlluminaMiSeq,
and de novo assembly (Fig. 1C) to generate 27 complete or nearly
complete genomes (11 group A and 16 group B; median length,
14,990 nt; range, 14,666 to 15,232 nt). An additional number of
samples yielded RSV contigs of 5,000 nt in length, and these
were also retained for further analysis. A summary of the genomic
sequences in this study is provided in Table 2.
RSV global phylogenetic clustering and placement of Kilifi
genomes. The 27 Kilifi genomes were combined with RSVA and
RSVB genomes from 16 countries from specimens collected be-
tween the years 1981 and 2013 (see Materials and Methods). The
phylogenetic clustering is shown in Fig. 2A (RSVA) andB (RSVB).
Patterns of RSV Evolution from Full-Genome Sequencing
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RSVA forms 3major clades: GA1 (including strains only from the
United States), GA5 (with U.S. and global strains), and a clade
with both GA2 and the ON1 viruses with a 72-nucleotide dupli-
cation in the G ORF (33), which included nearly all of the new
Kilifi RSVA genomes (GA2_ON1). Multiple subclusters showing
temporal clustering were detected within each of these clades.
Four clades were designated for the RSVB genomes, with BA
containing the majority of the Kilifi sequences (Fig. 2B). Clade
TABLE 1 Summary of RSV primers used in this study
Target Primer Sequence (5= to 3=) Strand Positiona Tm (°C)b
% with 0
MMc
% with 0–3
MMd
RSVA rsvas ACGCGAAAAAATGCGTACAAC Plus 1 57.13 18.28 18.97
RSVA rsva52 TGTGCATGTTATTACAAGTAGTGATATTTG Plus 266 56.96 95.52 98.97
RSVA rsva50 GCATGTTATTACAAGTAGTGATATTTGCC Plus 269 57.51 95.17 98.97
RSVA rsva117 ATAAGAGATGCCATGGTTGGTTTAAGA Plus 2849 58.44 95.86 100.00
RSVA rsva86 AAGAGATGCCATGGTTGGTTTAAGA Plus 2851 58.43 95.86 100.00
RSVA rsva175 TTCTCTTAAACCAACCATGGCATCT Minus 2878 58.43 95.86 100.00
RSVA rsva39 CTTCTCTTAAACCAACCATGGCATC Minus 2879 58.22 95.86 100.00
RSVA rsva1820 GCAGCATATGCAGCAACAATC Plus 5207 56.95 93.79 98.97
RSVA rsva1914 CAGCATATGCAGCAACAATCCAA Plus 5208 58.32 93.10 98.62
RSVA rsva1644 CAACTCCATTGTTATTTGCCCC Minus 5674 56.05 89.66 100.00
RSVA rsva1688 CAACTCCATTGTTATTTGCCCCA Minus 5674 57.54 89.66 100.00
RSVA rsva704 ATGTGTTGCCATGAGCAAACTC Plus 7893 57.95 91.03 100.00
RSVA rsva731 GCCATGAGCAAACTCCTCACT Plus 7900 58.49 71.38 99.31
RSVA rsva341 TTGTCAGGTAGTATCATTATTTTTGGCATG Minus 8196 58.53 98.97 99.31
RSVA rsva312 AGGATATTTGTCAGGTAGTATCATTATTTTTGG Minus 8203 58.08 98.97 100.00
RSVA rsva374 AAGAGAACTCAGTGTAGGTAGAATGTTT Plus 10360 57.89 96.55 100.00
RSVA rsva350 AGAACTCAGTGTAGGTAGAATGTTTG Plus 10363 56.64 96.55 100.00
RSVA rsva497 GCTTGATTGAATTTGCTGAGATCTGT Minus 10620 58.44 95.52 100.00
RSVA rsva539 ATGCTTGATTGAATTTGCTGAGATCTG Minus 10622 58.68 95.52 100.00
RSVA rsva1220 GATTGGGTGTATGCATCTATAGATAACAAG Plus 12386 57.94 95.86 99.31
RSVA rsva1232 ATTGGGTGTATGCATCTATAGATAACAAG Plus 12387 57.17 95.86 99.31
RSVA rsva364 TTATATATCCCTCTCCCCAATCTTTTTCAAA Minus 13070 58.32 96.21 100.00
RSVA rsva385 ATCAGTTATATATCCCTCTCCCCAATCTT Minus 13075 58.46 96.21 100.00
RSVA rsva4066 GTTGTATAACAAACTACCTGTGATTTTAATCAG Minus 14983 57.95 88.97 99.31
RSVA rsva5632 TAACTATAATTGAATACAGTGTTAGTGTGTAGC Minus 15063 57.95 29.31 95.17
RSVA rsvae ACGAGAAAAAAAGTGTCAAAAACTAATA Minus 15223 55.09 17.59 18.28
RSVB rsvbs ACGCGAAAAAATGCGTACTACA Plus 1 57.56 43.14 43.14
RSVB rsvb3 TGGGGCAAATAAGAATTTGATAAGTGC Plus 44 58.58 48.04 54.90
RSVB rsvb1021 GGGGCAAATAAGAATTTGATAAGTGCTATT Plus 45 58.75 47.06 54.90
RSVB rsvb33 ATATTAGGAATGCTCCATACATTAGTAGTTG Plus 2777 57.21 88.24 100.00
RSVB rsvb71 TAAGAGATGCTATGGTTGGTCTAAGAGA Plus 2841 58.69 90.20 100.00
RSVB rsvb50 AGTCTTGCCATAGCCTCTAACCT Minus 2937 58.57 93.14 100.00
RSVB rsvb95 CCATTTTTTCGCTTTCCTCATTCCTA Minus 2963 58.14 95.10 100.00
RSVB rsvb7884 AGTATATGTGGCAACAATCAACTCTG Plus 5202 57.48 81.37 100.00
RSVB rsvb7996 TATGTGGCAACAATCAACTCTGC Plus 5206 57.70 81.37 100.00
RSVB rsvb7442 GATGTGGAGGGCTCGGATG Minus 5548 57.92 75.49 100.00
RSVB rsvb7423 CCATGGTTATTTGCCCCAGATTTAAT Minus 5662 57.87 77.45 99.02
RSVB rsvb3762 AGAGGTCATTGCTTGAATGGTAGAA Plus 7642 57.98 93.14 100.00
RSVB rsvb3712 AAGAGCATAGACACTTTGTCTGAAATAAG Plus 7762 57.89 77.45 100.00
RSVB rsvb3652 GCTTATGGTTATGCTTTTGTGGATATCTAAT Minus 8130 58.41 89.22 98.04
RSVB rsvb3660 GCAATCATGCTTTCACTTGAGATCAA Minus 8247 58.67 64.71 98.04
RSVB rsvb32 AAGAAGAGTACTAGAGTATTACTTGAGAGATAA Plus 10236 57.04 90.20 100.00
RSVB rsvb52 AAATCCAAATCTTAGCAGAGAAAATGATAG Plus 10412 56.70 96.08 100.00
RSVB rsvb47 CCATGCAGTTCATCTAATACATCACTG Minus 10673 58.13 90.20 99.02
RSVB rsvb168 TGCATGTCTATATGTACATATTATTGTGACAAG Minus 10746 58.25 91.18 99.02
RSVB rsvb651 ATCGACATTGTGTTTCAAAATTGCATAAG Plus 12640 58.40 81.37 100.00
RSVB rsvb165 TTCAAAATTGCATAAGTTTTGGTCTTAGC Plus 12653 58.06 88.24 100.00
RSVB rsvb27 TTAATGAACATATGATCAGTTATATACCCCTCT Minus 13088 57.88 79.41 100.00
RSVB rsvb60 AACTTAAAACTGTGACAGCCTTTTATTCT Minus 13325 58.08 89.22 100.00
RSVB rsvb1199 ATAGTACACTACCTGTTATTTTAATCAGCTTCT Minus 14977 58.56 88.24 100.00
RSVB rsvb989 TATAGTACACTACCTGTTATTTTAATCAGCTTC Minus 14978 57.57 88.24 100.00
RSVB rsvbe ACGAGAAAAAAAGTGTCAAAAACTAATGT Minus 15216 57.47 5.88 6.86
a Primer mapping position in RSVA (GenBank accession number FJ948820) or RSVB (GenBank accession number JQ582843).
b Tm (melting temperature) calculated using a Python script that approximates the method of Breslauer et al. (51).
c Percentage of full-length RSVA genomes (n 290) or full-length RSVB genomes (n 102) showing perfect homology to primer, i.e., 0 mismatches (MM).
d Percentage of full-length RSVA genomes (n 290) or full-length RSVB genomes (n 102) showing the target sequence for the primer with up to 3 mismatches.
Agoti et al.
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GB1_GB4 included viruses detected in the United States between
1983 and 1991. Clades SAB1, GB3, and BA included viruses from
multiple countries, including the Kilifi RSVB genomes. Similar to
that for RSVA, the clustering was more temporal than geograph-
ical. Notably, the BA (Buenos Aires) clade viruses are character-
ized by the presence of a 60-nucleotide duplication within the G
ORF. The 4 viruses within clade GB3 (3 from Kilifi and 1 from
Germany) lacked the 60-nucleotide duplication. Neither RSVA
nor RSVB genomes from Kilifi showed a monophyletic grouping.
Instead, the Kilifi genomes were dispersed throughout the ob-
served RSV evolution, clustering with contemporaneous genomes
from the other countries. The phylogenetic tree topologies arising
from whole-genome and G protein ORF sequences were highly
similar (data not shown).
Comparison of genomes of viruses with identical G protein
ORFs. One motivation for developing full-genome methods was
to increase the sensitivity for tracking RSV across short-term
transmission chains. We asked if viruses identical in their G gene
regions had differences elsewhere in their genomes. All RSV ge-
nomes (both GenBank or in the new data presented here) with
identical G regions were identified, and the number of changes
outside the G region were determined. Of 7 sets of viruses with
identical G regions, all showed at least 1 but up to 9 nucleotide
differences across the full genome (Fig. 3). This increased resolu-
TABLE 2 Details for samples used in this study
MiSeq
Age
(mo)
Sample date
(day-mo-yr) Group Length (nt)a Coverageb
Present in
G setc
Present in
F setd GenBank no.e ENA no.f
10028_10 0 07-Jan-02 A 9,346 6,401 Yes KP317918 ERR323212
10028_11 6 27-Apr-02 A 7,091 10,370 KP317940 ERR323213
10028_12 6 28-Jan-03 A 9,776 5,692 Yes KP317955 ERR323214
11866_65 5 13-Feb-03 A 12,151 7,347 Yes Yes KP317949 ERR438932
11865_75 8 24-Mar-04 A 14,985 12,283 Yes Yes KP317956 ERR438910
10891_50 6 21-Jan-05 A 5,396 3,554 Yes Yes KP317948 ERR376407
10891_56 0 02-Feb-05 A 5,396 2,369 Yes Yes KP317924 ERR376413
9696_45 14 20-Feb-06 A 14,778 3,830 Yes Yes KP317944 ERR303303
10891_57 1 23-Feb-06 A 14,841 4,640 Yes Yes KP317942 ERR376414
10891_58 0 29-Mar-06 A 8,864 6,016 KP317943 ERR376415
10891_59 3 04-Jan-07 A 11,496 5,316 Yes KP317937 ERR376416
10891_60 1 05-Jan-07 A 14,791 4,454 Yes Yes KP317926 ERR376417
10891_51 0 07-Mar-08 A 14,967 4,882 Yes Yes KP317933 ERR376408
10891_52 11 17-Mar-08 A 5,636 1,201 Yes KP317931 ERR376409
10899_38 1 22-Feb-09 A 14,854 8,478 Yes Yes KP317950 ERR381723
10899_40 4 26-Jan-10 A 10,113 13,351 Yes KP317916 ERR381725
10899_41 18 10-Feb-10 A 14,713 12,405 Yes Yes KP317935 ERR381726
11864_54 3 29-Apr-10 A 14,716 7,071 Yes Yes KP317936 ERR438905
11862_33 3 26-Aug-10 A 14,719 8,961 Yes Yes KP317921 ERR438868
11864_53 1 25-Mar-11 A 14,735 6,891 Yes Yes KP317951 ERR438904
11862_28 28 13-Apr-11 A 15,214 10,434 Yes Yes KP317920 ERR438864
11862_29 4 23-Mar-12 A 14,950 12,922 Yes Yes KP317953 ERR438865
11862_32 14 30-Apr-12 A 7,197 6,180 KP317947 ERR438867
9697_16 10 06-Jul-02 B 15,040 5,419 Yes Yes KP317939 ERR303322
9697_10 8 13-Jan-03 B 9,790 6,853 Yes KP317930 ERR303316
10140_1 46 02-Apr-04 B 12,034 12,174 Yes Yes KP317919 ERR331021
9697_7 10 22-Dec-04 B 15,080 4,480 Yes Yes KP317925 ERR303313
9697_6 2 25-Dec-04 B 14,998 6,523 Yes Yes KP317954 ERR303312
9697_5 1 27-Jan-06 B 15,234 3,682 Yes Yes KP317917 ERR303311
9465_10 23 27-Feb-09 B 14,995 16,190 Yes Yes KP317938 ERR303268
9465_11 31 13-Feb-10 B 15,004 11,722 Yes Yes KP317941 ERR303269
9465_12 22 06-Apr-10 B 15,260 14,855 Yes Yes KP317932 ERR303270
9465_6 17 09-May-10 B 15,333 13,719 Yes Yes KP317952 ERR303264
9465_7 3 01-Feb-11 B 15,233 14,182 Yes Yes KP317927 ERR303265
9465_8 2 14-Apr-11 B 15,323 15,367 Yes Yes KP317945 ERR303266
9465_9 1 08-Jul-11 B 15,237 14,709 Yes Yes KP317928 ERR303267
9465_3 8 14-Jan-12 B 14,995 12,378 Yes Yes KP317946 ERR303261
9465_1 19 13-Feb-12 B 15,233 12,994 Yes Yes KP317934 ERR303259
9465_4 14 01-Mar-12 B 15,179 14,802 Yes Yes KP317923 ERR303262
10911_9 1 23-Mar-12 B 14,977 12,504 Yes Yes KP317929 ERR376442
9465_2 5 16-May-12 B 14,941 12,906 Yes Yes KP317922 ERR303260
a Final sequence length obtained from de novo assembly of short read data (see Materials and Methods).
b Coverage calculated by mapping all reads to final assembled contig. Coverage was calculated as the number of mapped reads/(length of the genome fragment/129).
c Samples yielding sufficient sequence for G region analysis (Fig. 5).
d Samples yielding sufficient sequence for F region analysis (Fig. 5).
e The final genome data were deposited in GenBank with the indicated accession numbers.
f Short-read data available at European Nucleotide Archive (http://www.ebi.ac.uk/ena).
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tionwill be important in future studies examining RSV household
transmission patterns to identify who acquires infection from
whom.
Estimation of RSV tMRCA and evolutionary rates. Previous
data on RSV evolution are largely derived from the G protein
coding region. The full genomes generated in this studywere com-
bined with the GenBank reference data set, and these allowed an
estimation of the global nucleotide substitution rates and the time
to most recent common ancestor (tMRCA) for all the recently
sequenced RSVA and RSVB viruses. These estimates were calcu-
FIG 1 (A) PCR primer target sites in RSVA and RSVB. The primer target sequences in representative RSVA (left) and RSVB (right) viruses were determined.
Circularmarkers indicate positions of primer target sites in the test genome color-coded by number ofmismatcheswith the primer; gray bars indicate lengths and
positions of the predicted products. (B) Two examples of reverse transcription-PCR function. TheDNAproducts of reverse transcription and PCR amplification
of two samples were resolved by agarose gel electrophoresis and visualized by ethidium bromide staining. Sizes of some of the molecular size markers (in base
pairs) are indicated to left of the gel. Lane m, molecular size markers; lanes 1 to 6, individual 2- to 3-kb RSV amplicons 1 to 6, respectively. (C) Flowchart of the
RSV sequencing process.
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lated for the different ORFs and the whole-genome sequences
(Fig. 4). The whole genomes provided more precise estimates of
theMRCA, as observed from the interval of lower and upper 95%
highest posterior density (HPD) compared to individual ORF
data for the same set of viruses (Fig. 4B).
TheG proteinORF showed the highest nucleotide substitution
rates for both RSVA and RSVB (Fig. 4A). Elevated changes in G
andM2-2 were observed previously using RSV full genomes from
U.S. and European cohort data (21). Similar to the MRCA esti-
mates, the whole-genome estimates for the evolutionary rates
showed narrower confidence intervals than those from the indi-
vidual ORFs. The two regions considered for vaccine targets, G
and F, show a strikingly wide difference in rate, and this may be
important for selecting conserved vaccine targets.
Changes in G and F coding regions, comparing local and
global viruses. An important consideration for vaccine develop-
ment is how representative a vaccine strain is for locally circulat-
ing viruses. The transmission patterns of a virus, the evolutionary
rate of the virus, and patterns of human movement can strongly
influence how quickly global strains reach a rural location. To
address this important issue, the amino acid changes encoded by
the RSV coding sequences observed in Kilifi were compared to the
amino acid changes observed for all known RSV genomes from
other parts of the world (Fig. 5; Table 3).
A large percentage of the changes observed in the RSVA G
protein were also observed globally, with 88% of the changes seen
in Kilifi RSVA G also observed in other parts of the world (Table
3). The Kilifi RSVB viruses appeared to havemore local evolution,
with only 60% of the observed changes in G shared with global
viruses. With reference to the F protein, for Kilifi RSVA viruses,
80% of the observed changes were also found globally, while the
Kilifi RSVB viruses showed a higher degree of local evolution, with
only 20% of the observed changes specific to Kilifi viruses seen in
other locations. To determine if this local evolution of RSVB was
observed at other sites, the sequence data were stratified to other
locations (the United States, Argentina, and Peru), but no signif-
icant local patterns were observed. This suggests that the isolation
of the Kilifi site was more pronounced than for other sites. Alter-
natively, this may reflect more intense sampling of RSVB within a
limited area.
The RSV envelope proteins are heavily glycosylated.More than
50% of the G protein mass can be carbohydrate (37), and the
potential O-linked glycosylation sites (serine or threonine) com-
prise up to 30% of the G protein amino acid sequence (38).
Changes toward or away from asparagine can be associated with a
change in the overall glycosylation of the protein and could be
associatedwith adaptive change to local immune responses. TheG
protein is subject to heavy O-linked glycosylation in the variable
FIG 2 Phylogenetic analysis of the Kilifi RSVA and RSVB genomes. (A)MrBayes tree of representative global RSVA genome sequences together and the 11 novel
Kilifi RSVA genome sequences. (B) MrBayes tree of representative global RSVB genome sequences and the 16 novel Kilifi RSVA genome sequences. Trees were
inferred using the Bayesian methods in MrBayes (http://mrbayes.sourceforge.net/index.php) under the GTR model of evolution. The numbers next to the
branches indicate the posterior probabilities. The Kilifi taxa are indicated in red font. Thinned global reference sets for RSVA and RSVB were prepared from all
available RSV genomes clustering at 0.99% identity using uclust (32). See Materials and Methods for additional details.
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regions, with modification frequently on serine or threonine res-
idues in the vicinity of a proline residue (Fig. 5A). Nearly half of
the observed changes in the in G protein affect S, T, or P residues
(RSVA GA2 37/81 and RSVB 100/241). This is apparent when
potential N- andO-linked glycosylation sites are marked on the G
protein region (Fig. 5) and is also facilitated by the single nucleo-
tide changes that distinguish codons for these three amino acids.
In the RSVAGproteins, anN237D polymorphism observed in
many of the viruses is within the site NTT and would remove a
predicted N-linked glycosylation site. Tan et al. (22) also noted
that the RSVA-GA2 group showed a frequent change in two pre-
dicted glycosylation sites (N237D and S242N). Within the RSVB
viruses, 3 of 15 amino acid changes involve asparagine, but none
of these changes are predicted N-linked glycosylation sites (Asn-
Xaa-Ser/Thr). Changes in N-linked glycosylation areas are known
to effect binding of human convalescent-phase sera to peptides
(39).
The RSV F protein contains only 10 to 20% of its mass as
carbohydrate, and this is attached exclusively via N-glycosidic
bonds (37). For the RSVA viruses, 5 of the protein changes are to
or away from asparagine. In RSVB, 3 changes involve asparagine;
however, none of these are within predicted glycosylation sites.
Many polymorphisms were observed in the F protein p27 domain
(Fig. 5B). This peptide is likely to serve as a spacer that is freed by
cleavage during F maturation and is not found in the mature pro-
tein. The large number of changes may simply reflect the dispos-
able nature of this sequence (40).
The NS2 protein may be important in modulating host innate
immune responses (41–43) and may influence movement of in-
fected cells (44). TheNS2 showed an elevated level of evolutionary
rate (Fig. 4), consistent with a protein interacting with polymor-
phic host target proteins. Monitoring the local versus global pro-
tein changes in NS2 revealed multiple changes occurring in the
amino-terminal domain and a portion of the domain important
for TRAF3 interactions (43). The majority of changes in the Kilifi
RSVANS2 proteins were also observed in other parts of the world;
however, the RSVB NS2 protein showed a significantly high de-
gree of variation only observed in the Kilifi viruses (Fig. 5C).
DISCUSSION
The current work presents a functional approach for commu-
nity-wide monitoring of RSV whole-genome genetic diversity
suitable for detailed transmission studies. A challenge with
deep sequencing of large sample sets of RNA viruses is the
design of amplification primers. Traditionally, PCR primers
were designed using alignments of sequences from the target
virus; previous RSV studies with dideoxy sequencing used a
greater number of tiled amplicons (2, 24, 25, 38) to cover the
whole genome. With larger and more diverse sets, the align-
ment step becomes problematic. The approach described here
bypasses the alignment step and was tailored for deep-sequenc-
ing methods. The RSVmethod uses only 6 amplicons to reduce
the amplification costs and the required amount of input RNA.
Although two primer sets were designed for RSVA and RSVB,
FIG 3 Comparison of RSVB genomes with identical G regions. Each panel represents a genome nucleotide alignment of RSVs that had identical G gene
sequences. The G protein ORF portions of the genomes are highlighted gray across the panels and were identical. The vertical lines indicate where there are
nucleotide substitutions occurring outside the G gene region between the genomes. The blue blocks indicate a gap in the sequence.
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the two sets can be pooled to simplify processing of samples of
unknown RSV subtype. The computational methods used for
primer selection facilitates updating of the primer sets as addi-
tional RSV genome sequence data become available. Frequent
updating of these primer sets will help avoid sequence bias that
could occur using antiquated primer sets. It is also important
that the new full genomes reported here were assembled using
de novo assembly methods. Although reference-based methods
for assembling genomes from short-read data are rapid and less
memory intensive, reference-based methods fail if a close ref-
erence genome is not available. The method presented here
determines virus genomic sequences directly from patient ma-
terial and shows sensitivity similar to that of traditional se-
quencing methods, but it avoids the potential virus selection
that may occur if samples are first passaged through cell cul-
ture.
The 27 novel Kilifi RSV genomes (11 RSVA and 16 RSVB)
generated in this study were used to assess local versus global RSV
variety. Similar to the patterns previously observed with G ORF,
the full genomic phylogenetic analysis confirmed that Kilifi ge-
nomeswere interspersedwith genomes fromother countries, with
rapid appearance of variants in Kilifi soon after they are first ob-
served in other parts of the world (45). Kilifi RSV strains are sim-
ilar to strains that circulate in other regions of theworld and reveal
only limited local evolution. Phylogenetic clustering appeared to
be more influenced by time of virus sample collection than by
geographical location, suggesting a fairly rapid global spread of
novel RSV variants. It should also be noted that the similarity of
the overall topology of phylogenetic trees from whole genomes
and G sequences is encouraging and indicates that although full-
genome sequences are most useful for detailed transmission stud-
ies, the relationships determinedwith theG region is similar to the
patterns observed with the full-genome sequences.
The availability of full genomes allowed a comparison of esti-
mates of the tMRCA of the Kilifi RSV strains. The obtained
tMRCAs were broadly similar, although the higher evolutionary
rates of the G region lead, as expected, to slightly later tMRCAs.
The estimates based on the entire genomes lead to earlier dates
and more discrete confidence intervals than estimates from spe-
cific genomic regions. Similar observations were made by Tan et
al. (22).
Our comparison of genomes determined to be identical in the
G region found nucleotide substitutions elsewhere in their ge-
nomes. The genomes with identical G regions invariably were
from the same geographical region and over the same epidemic,
the sample collection date interval ranging from a few days to
months. This observation suggests that nucleotide substitution in
the RSV genome in the short term is random, i.e., not concen-
trated in the regions that appear the most variable in the long
term, and supports the use of whole-genome sequencing formon-
itoring viral transmission chains.
The observed sites of change in the G and F proteins were
frequently in exposed regions of the proteins; several involved
glycosylation site changes suggestive of immune evasion. In addi-
tion, similar to previous reports, the NS2 (Fig. 5B) and M2-2
protein coding regions (not shown) were observed to change at
rates higher than that for the full genome. Although these changes
could be simply the allowed changes of unconstrained proteins, it
is also possible that these sites are important for interacting with
the host and may be under some pressure to change. Unfortu-
nately, the sequence data set generated in this study was too small
to provide statistically supported evidence of positive selection,
but future studies with larger data sets will be facilitated by these
methods.
The availability of a collection of RSV genome sequences from
a single African location allowed a comparison of local versus
global RSV evolution patterns. Important for vaccine design, the
RSVA variants observed in a small region of Kenya appear to be in
equilibrium with global variants. The same was not observed for
RSVB. Possibly, RSVB variants may spread less efficiently, with a
higher fraction of variants observed to be specific for Kilifi and not
detected in other parts of theworld. This pattern is consistent with
RSVB as a less transmissible infection than RSVA (4, 12). How-
ever, there are fewer global sequences available for RSVB, so while
the Kilifi RSVB variants appear to be unique, this could be a con-
sequence of less surveillance and documentation of RSVB varia-
tion globally. Future work will help clarify this phenomenon, as it
FIG 4 (A) Estimates of the nucleotide substitution rates for RSVA and RSVB
in the individual ORFs and for the whole-genome sequence. (B) Estimates of
tMRCA for RSVA and RSVB for the individual ORFs and for the whole-ge-
nome sequence. The analysis was undertaken using the usearch-thinned data
sets (37 genome sequences for RSVA and 23 sequences for RSVB). The analysis
was performed with BEAST (36).
Patterns of RSV Evolution from Full-Genome Sequencing
April 2015 Volume 89 Number 7 jvi.asm.org 3451Journal of Virology
 o
n
 Septem
ber 17, 2019 at SW
ETS SUBSCRIPTIO
N SERVICE
http://jvi.asm.org/
D
ow
nloaded from
 
FIG 5 Kilifiversus global changes in theG,F, andNS2proteins. (A)Kilifi compared toglobalGprotein changes. For eachgroup, theGprotein sequenceswere identified
asKilifiornon-Kilifi (global) andaligned, anda consensus aminoacid sequencewas generated (at 60% level). Thefirst portion shows thepositionsofO-linked (red) and
N-linked (blue) glycosylation sites, the second portion shows general features of the G protein, and the third portion shows total changes (Kilifi plus global) at each
position. The fourth portion shows amino acid differences in each G sequence from the consensus. Amino acid changes observed only in Kilifi are marked in red, and
changes observed either globally or in the Kilifi aremarked in gray. Gaps are not indicated. N-linked andO-linked glycosylation sites were determined usingNetNGlyc
1.0 and NetOGlyc 3.1 (46–48). (B) Kilifi versus global F protein changes. Changes in F protein were determined and are depicted as in panel A. Knownmotifs of the F
protein (49) include signal peptide (SP), heptad repeat C (HRC), 27-mer fragment (p27), putative fusion peptide (FP), heptad repeat A (HRA), domains 1 and 2
(Dom1&2), heptad repeat B (HRB), transmembrane domain (TM), and cytoplasm domain (CP). Antigenic sites I, II, and IV (ASI, ASII, and ASIV) are sites of
neutralizing antibody binding (40, 50). (C) Kilifi versus global NS2 protein changes. Changes in NS2 protein were determined and are depicted as in panel A. Known
motifs of the NS2 protein include the TRAF3-interacting domain (TRAF3-ID) and C-terminal tetrapeptide sequence (DLNP) (43).
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may have strong consequences on the efficacy of any RSV vaccine
used locally.
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